Multiple Myeloma News - HealthTree for Myeloma

Myeloma News

It's important for multiple myeloma patients to stay up-to-speed on myeloma news because the treatment options are rapidly changing. Additionally, myeloma patients need to look ahead at their treatment options, so knowing about the latest is helpful for patients to make key life-saving decisions.

One of our goals for the Myeloma News category is to help patients understand these updates in understandable language.

In Myeloma News, we cover:

- MRD and other testing updates

- Key research findings by multiple myeloma experts and researchers

- New drug classes and treatment targets for multiple myeloma

- Findings from major myeloma meetings like ASH, ASCO, IMW, EHA and more

- Progress of myeloma therapies in development as they go through the FDA approval process

- FDA drug approvals

Ide-Cel (ABECMA) muestra mejores resultados en comparación con el tratamiento estándar del mieloma en pacientes en recaída

May 24, 2023

Ide-cel (Abecma) demostró tener una mejor supervivencia libre de progresión en comparación con las terapias estándar para el mieloma en recaída o refractario

Ensayo clínico: tamizaje para mejorar la supervivencia en amiloidosis primaria

May 19, 2023

Se está llevando a cabo un ensayo clínico para comprobar si determinados genes están implicados en el desarrollo de la amiloidosis.

HealthTree Launches New and Improved University Platform for Myeloma Patients

May 14, 2023

HealthTree Launches New and Improved University Platform for Myeloma Patients

Producción de células CAR-T dentro del cuerpo

May 11, 2023

Hay un nuevo avance con el potencial de cambiar el costo y el tiempo para la producción de células CAR-T.

What Treatments Can be Used Following a BCMA Relapse in Myeloma?

May 04, 2023

Gurbakhash Kaur, MD from UT Southwestern shares how various options are still available for patients, even after a BCMA treatment relapse in multiple myeloma.